nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A5—prostate cancer	0.226	0.698	CbGaD
Alprazolam—CYP3A4—prostate cancer	0.0976	0.302	CbGaD
Alprazolam—CYP3A5—Flutamide—prostate cancer	0.0334	0.0816	CbGbCtD
Alprazolam—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0299	0.0731	CbGbCtD
Alprazolam—CYP2C9—Bicalutamide—prostate cancer	0.027	0.0661	CbGbCtD
Alprazolam—CYP2C9—Nilutamide—prostate cancer	0.027	0.0661	CbGbCtD
Alprazolam—CYP3A5—Cabazitaxel—prostate cancer	0.0247	0.0604	CbGbCtD
Alprazolam—CYP3A5—Estrone—prostate cancer	0.0242	0.059	CbGbCtD
Alprazolam—CYP3A7—Estradiol—prostate cancer	0.0185	0.0452	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0185	0.0452	CbGbCtD
Alprazolam—CYP2C9—Estrone—prostate cancer	0.0162	0.0396	CbGbCtD
Alprazolam—CYP3A4—Bicalutamide—prostate cancer	0.0157	0.0384	CbGbCtD
Alprazolam—CYP3A4—Estramustine—prostate cancer	0.0146	0.0357	CbGbCtD
Alprazolam—CYP3A5—Estradiol—prostate cancer	0.0139	0.0339	CbGbCtD
Alprazolam—CYP3A4—Flutamide—prostate cancer	0.013	0.0318	CbGbCtD
Alprazolam—CYP3A4—Abiraterone—prostate cancer	0.013	0.0318	CbGbCtD
Alprazolam—CYP2C9—Capecitabine—prostate cancer	0.0123	0.03	CbGbCtD
Alprazolam—CYP3A7—Docetaxel—prostate cancer	0.011	0.027	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.011	0.027	CbGbCtD
Alprazolam—CYP3A4—Cabazitaxel—prostate cancer	0.00964	0.0235	CbGbCtD
Alprazolam—CYP3A4—Estrone—prostate cancer	0.00942	0.023	CbGbCtD
Alprazolam—CYP2C9—Estradiol—prostate cancer	0.0093	0.0227	CbGbCtD
Alprazolam—CYP3A5—Etoposide—prostate cancer	0.00906	0.0221	CbGbCtD
Alprazolam—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00839	0.0205	CbGbCtD
Alprazolam—CYP3A5—Docetaxel—prostate cancer	0.00829	0.0203	CbGbCtD
Alprazolam—CYP3A4—Conjugated Estrogens—prostate cancer	0.00616	0.0151	CbGbCtD
Alprazolam—CYP3A4—Mitoxantrone—prostate cancer	0.0056	0.0137	CbGbCtD
Alprazolam—CYP3A4—Estradiol—prostate cancer	0.00541	0.0132	CbGbCtD
Alprazolam—CYP3A4—Prednisone—prostate cancer	0.00465	0.0114	CbGbCtD
Alprazolam—CYP3A4—Etoposide—prostate cancer	0.00353	0.00863	CbGbCtD
Alprazolam—CYP3A4—Docetaxel—prostate cancer	0.00323	0.0079	CbGbCtD
Alprazolam—CYP3A4—Doxorubicin—prostate cancer	0.00241	0.00589	CbGbCtD
Alprazolam—Lorazepam—UGT2B15—prostate cancer	0.000705	0.174	CrCbGaD
Alprazolam—Oxazepam—UGT2B15—prostate cancer	0.00037	0.0911	CrCbGaD
Alprazolam—Oxazepam—CYP3A43—prostate cancer	0.000321	0.079	CrCbGaD
Alprazolam—Clonazepam—NAT2—prostate cancer	0.000308	0.0758	CrCbGaD
Alprazolam—Clobazam—CYP2C18—prostate cancer	0.000172	0.0422	CrCbGaD
Alprazolam—Diazepam—CYP2C18—prostate cancer	0.0001	0.0247	CrCbGaD
Alprazolam—Flunitrazepam—CYP2A6—prostate cancer	0.0001	0.0246	CrCbGaD
Alprazolam—Midazolam—SLC22A1—prostate cancer	9.54e-05	0.0235	CrCbGaD
Alprazolam—Clonazepam—CYP2E1—prostate cancer	8.86e-05	0.0218	CrCbGaD
Alprazolam—Triazolam—CYP3A5—prostate cancer	8.29e-05	0.0204	CrCbGaD
Alprazolam—Oxazepam—CYP3A5—prostate cancer	8.04e-05	0.0198	CrCbGaD
Alprazolam—Flurazepam—CYP2A6—prostate cancer	8.04e-05	0.0198	CrCbGaD
Alprazolam—Midazolam—CYP3A5—prostate cancer	7.7e-05	0.019	CrCbGaD
Alprazolam—Clobazam—CYP2C19—prostate cancer	7.69e-05	0.0189	CrCbGaD
Alprazolam—Quazepam—CYP2C19—prostate cancer	7.46e-05	0.0184	CrCbGaD
Alprazolam—Flunitrazepam—CYP2E1—prostate cancer	7.11e-05	0.0175	CrCbGaD
Alprazolam—Flunitrazepam—CYP2C19—prostate cancer	7.04e-05	0.0173	CrCbGaD
Alprazolam—Ketazolam—CYP3A4—prostate cancer	6.92e-05	0.017	CrCbGaD
Alprazolam—Diazepam—CYP3A5—prostate cancer	6.6e-05	0.0162	CrCbGaD
Alprazolam—Nitrazepam—CYP2E1—prostate cancer	6.42e-05	0.0158	CrCbGaD
Alprazolam—Adinazolam—CYP2C19—prostate cancer	6.27e-05	0.0154	CrCbGaD
Alprazolam—Chlordiazepoxide—CYP3A4—prostate cancer	5.77e-05	0.0142	CrCbGaD
Alprazolam—Flurazepam—CYP2E1—prostate cancer	5.71e-05	0.014	CrCbGaD
Alprazolam—Clonazepam—CYP3A4—prostate cancer	5.58e-05	0.0137	CrCbGaD
Alprazolam—Temazepam—CYP2C19—prostate cancer	5.4e-05	0.0133	CrCbGaD
Alprazolam—Clorazepate—CYP3A4—prostate cancer	5.4e-05	0.0133	CrCbGaD
Alprazolam—Midazolam—CYP2E1—prostate cancer	5.29e-05	0.013	CrCbGaD
Alprazolam—Clobazam—CYP3A4—prostate cancer	4.89e-05	0.012	CrCbGaD
Alprazolam—Quazepam—CYP3A4—prostate cancer	4.74e-05	0.0117	CrCbGaD
Alprazolam—Diazepam—CYP2E1—prostate cancer	4.53e-05	0.0112	CrCbGaD
Alprazolam—Diazepam—CYP2C19—prostate cancer	4.49e-05	0.0111	CrCbGaD
Alprazolam—Syncope—Prednisone—prostate cancer	4.48e-05	0.000237	CcSEcCtD
Alprazolam—Flunitrazepam—CYP3A4—prostate cancer	4.48e-05	0.011	CrCbGaD
Alprazolam—Tachycardia—Capecitabine—prostate cancer	4.47e-05	0.000237	CcSEcCtD
Alprazolam—Hypoaesthesia—Epirubicin—prostate cancer	4.47e-05	0.000237	CcSEcCtD
Alprazolam—Skin disorder—Capecitabine—prostate cancer	4.45e-05	0.000236	CcSEcCtD
Alprazolam—Sweating—Doxorubicin—prostate cancer	4.43e-05	0.000235	CcSEcCtD
Alprazolam—Urinary tract disorder—Epirubicin—prostate cancer	4.43e-05	0.000235	CcSEcCtD
Alprazolam—Hyperhidrosis—Capecitabine—prostate cancer	4.42e-05	0.000234	CcSEcCtD
Alprazolam—Oedema peripheral—Epirubicin—prostate cancer	4.42e-05	0.000234	CcSEcCtD
Alprazolam—Hypotension—Docetaxel—prostate cancer	4.42e-05	0.000234	CcSEcCtD
Alprazolam—Connective tissue disorder—Epirubicin—prostate cancer	4.41e-05	0.000234	CcSEcCtD
Alprazolam—Urethral disorder—Epirubicin—prostate cancer	4.4e-05	0.000233	CcSEcCtD
Alprazolam—Loss of consciousness—Prednisone—prostate cancer	4.39e-05	0.000233	CcSEcCtD
Alprazolam—Hepatobiliary disease—Doxorubicin—prostate cancer	4.37e-05	0.000232	CcSEcCtD
Alprazolam—Epistaxis—Doxorubicin—prostate cancer	4.36e-05	0.000231	CcSEcCtD
Alprazolam—Anorexia—Capecitabine—prostate cancer	4.36e-05	0.000231	CcSEcCtD
Alprazolam—Nausea—Estradiol—prostate cancer	4.36e-05	0.000231	CcSEcCtD
Alprazolam—Vomiting—Mitoxantrone—prostate cancer	4.35e-05	0.00023	CcSEcCtD
Alprazolam—Convulsion—Prednisone—prostate cancer	4.33e-05	0.000229	CcSEcCtD
Alprazolam—Rash—Mitoxantrone—prostate cancer	4.31e-05	0.000228	CcSEcCtD
Alprazolam—Dermatitis—Mitoxantrone—prostate cancer	4.31e-05	0.000228	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.31e-05	0.000228	CcSEcCtD
Alprazolam—Headache—Mitoxantrone—prostate cancer	4.28e-05	0.000227	CcSEcCtD
Alprazolam—Hypotension—Capecitabine—prostate cancer	4.28e-05	0.000227	CcSEcCtD
Alprazolam—Insomnia—Docetaxel—prostate cancer	4.28e-05	0.000227	CcSEcCtD
Alprazolam—Arthralgia—Prednisone—prostate cancer	4.25e-05	0.000225	CcSEcCtD
Alprazolam—Myalgia—Prednisone—prostate cancer	4.25e-05	0.000225	CcSEcCtD
Alprazolam—Paraesthesia—Docetaxel—prostate cancer	4.24e-05	0.000225	CcSEcCtD
Alprazolam—Erythema multiforme—Epirubicin—prostate cancer	4.24e-05	0.000225	CcSEcCtD
Alprazolam—Anxiety—Prednisone—prostate cancer	4.24e-05	0.000225	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.22e-05	0.000224	CcSEcCtD
Alprazolam—Dyspnoea—Docetaxel—prostate cancer	4.21e-05	0.000223	CcSEcCtD
Alprazolam—Somnolence—Docetaxel—prostate cancer	4.2e-05	0.000223	CcSEcCtD
Alprazolam—Discomfort—Prednisone—prostate cancer	4.2e-05	0.000223	CcSEcCtD
Alprazolam—Eye disorder—Epirubicin—prostate cancer	4.19e-05	0.000222	CcSEcCtD
Alprazolam—Hypersensitivity—Etoposide—prostate cancer	4.19e-05	0.000222	CcSEcCtD
Alprazolam—Estazolam—CYP3A4—prostate cancer	4.19e-05	0.0103	CrCbGaD
Alprazolam—Tinnitus—Epirubicin—prostate cancer	4.18e-05	0.000222	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.17e-05	0.000221	CcSEcCtD
Alprazolam—Cardiac disorder—Epirubicin—prostate cancer	4.17e-05	0.000221	CcSEcCtD
Alprazolam—Dyspepsia—Docetaxel—prostate cancer	4.16e-05	0.00022	CcSEcCtD
Alprazolam—Hepatitis—Doxorubicin—prostate cancer	4.15e-05	0.00022	CcSEcCtD
Alprazolam—Insomnia—Capecitabine—prostate cancer	4.14e-05	0.000219	CcSEcCtD
Alprazolam—Hypoaesthesia—Doxorubicin—prostate cancer	4.13e-05	0.000219	CcSEcCtD
Alprazolam—Paraesthesia—Capecitabine—prostate cancer	4.11e-05	0.000218	CcSEcCtD
Alprazolam—Decreased appetite—Docetaxel—prostate cancer	4.11e-05	0.000218	CcSEcCtD
Alprazolam—Urinary tract disorder—Doxorubicin—prostate cancer	4.1e-05	0.000217	CcSEcCtD
Alprazolam—Oedema peripheral—Doxorubicin—prostate cancer	4.09e-05	0.000217	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Docetaxel—prostate cancer	4.08e-05	0.000216	CcSEcCtD
Alprazolam—Asthenia—Etoposide—prostate cancer	4.08e-05	0.000216	CcSEcCtD
Alprazolam—Connective tissue disorder—Doxorubicin—prostate cancer	4.08e-05	0.000216	CcSEcCtD
Alprazolam—Dyspnoea—Capecitabine—prostate cancer	4.08e-05	0.000216	CcSEcCtD
Alprazolam—Oedema—Prednisone—prostate cancer	4.08e-05	0.000216	CcSEcCtD
Alprazolam—Fatigue—Docetaxel—prostate cancer	4.08e-05	0.000216	CcSEcCtD
Alprazolam—Angiopathy—Epirubicin—prostate cancer	4.07e-05	0.000216	CcSEcCtD
Alprazolam—Urethral disorder—Doxorubicin—prostate cancer	4.07e-05	0.000216	CcSEcCtD
Alprazolam—Nausea—Mitoxantrone—prostate cancer	4.06e-05	0.000215	CcSEcCtD
Alprazolam—Infection—Prednisone—prostate cancer	4.05e-05	0.000215	CcSEcCtD
Alprazolam—Mediastinal disorder—Epirubicin—prostate cancer	4.04e-05	0.000214	CcSEcCtD
Alprazolam—Constipation—Docetaxel—prostate cancer	4.04e-05	0.000214	CcSEcCtD
Alprazolam—Nitrazepam—CYP3A4—prostate cancer	4.04e-05	0.00995	CrCbGaD
Alprazolam—Dyspepsia—Capecitabine—prostate cancer	4.03e-05	0.000213	CcSEcCtD
Alprazolam—Chills—Epirubicin—prostate cancer	4.03e-05	0.000213	CcSEcCtD
Alprazolam—Pruritus—Etoposide—prostate cancer	4.02e-05	0.000213	CcSEcCtD
Alprazolam—Shock—Prednisone—prostate cancer	4.01e-05	0.000213	CcSEcCtD
Alprazolam—Nervous system disorder—Prednisone—prostate cancer	4e-05	0.000212	CcSEcCtD
Alprazolam—Adinazolam—CYP3A4—prostate cancer	3.99e-05	0.00981	CrCbGaD
Alprazolam—Tachycardia—Prednisone—prostate cancer	3.98e-05	0.000211	CcSEcCtD
Alprazolam—Decreased appetite—Capecitabine—prostate cancer	3.98e-05	0.000211	CcSEcCtD
Alprazolam—Skin disorder—Prednisone—prostate cancer	3.96e-05	0.00021	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Capecitabine—prostate cancer	3.95e-05	0.000209	CcSEcCtD
Alprazolam—Fatigue—Capecitabine—prostate cancer	3.95e-05	0.000209	CcSEcCtD
Alprazolam—Hyperhidrosis—Prednisone—prostate cancer	3.94e-05	0.000209	CcSEcCtD
Alprazolam—Mental disorder—Epirubicin—prostate cancer	3.93e-05	0.000208	CcSEcCtD
Alprazolam—Erythema multiforme—Doxorubicin—prostate cancer	3.93e-05	0.000208	CcSEcCtD
Alprazolam—Constipation—Capecitabine—prostate cancer	3.91e-05	0.000207	CcSEcCtD
Alprazolam—Malnutrition—Epirubicin—prostate cancer	3.91e-05	0.000207	CcSEcCtD
Alprazolam—Feeling abnormal—Docetaxel—prostate cancer	3.9e-05	0.000206	CcSEcCtD
Alprazolam—Diarrhoea—Etoposide—prostate cancer	3.89e-05	0.000206	CcSEcCtD
Alprazolam—Anorexia—Prednisone—prostate cancer	3.89e-05	0.000206	CcSEcCtD
Alprazolam—Eye disorder—Doxorubicin—prostate cancer	3.88e-05	0.000206	CcSEcCtD
Alprazolam—Tinnitus—Doxorubicin—prostate cancer	3.87e-05	0.000205	CcSEcCtD
Alprazolam—Gastrointestinal pain—Docetaxel—prostate cancer	3.87e-05	0.000205	CcSEcCtD
Alprazolam—Prazepam—CYP3A4—prostate cancer	3.85e-05	0.00949	CrCbGaD
Alprazolam—Cardiac disorder—Doxorubicin—prostate cancer	3.85e-05	0.000204	CcSEcCtD
Alprazolam—Tension—Epirubicin—prostate cancer	3.83e-05	0.000203	CcSEcCtD
Alprazolam—Nervousness—Epirubicin—prostate cancer	3.79e-05	0.000201	CcSEcCtD
Alprazolam—Back pain—Epirubicin—prostate cancer	3.78e-05	0.0002	CcSEcCtD
Alprazolam—Feeling abnormal—Capecitabine—prostate cancer	3.77e-05	0.0002	CcSEcCtD
Alprazolam—Angiopathy—Doxorubicin—prostate cancer	3.77e-05	0.0002	CcSEcCtD
Alprazolam—Dizziness—Etoposide—prostate cancer	3.76e-05	0.000199	CcSEcCtD
Alprazolam—Muscle spasms—Epirubicin—prostate cancer	3.76e-05	0.000199	CcSEcCtD
Alprazolam—Gastrointestinal pain—Capecitabine—prostate cancer	3.74e-05	0.000198	CcSEcCtD
Alprazolam—Mediastinal disorder—Doxorubicin—prostate cancer	3.74e-05	0.000198	CcSEcCtD
Alprazolam—Abdominal pain—Docetaxel—prostate cancer	3.74e-05	0.000198	CcSEcCtD
Alprazolam—Body temperature increased—Docetaxel—prostate cancer	3.74e-05	0.000198	CcSEcCtD
Alprazolam—Chills—Doxorubicin—prostate cancer	3.73e-05	0.000197	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Prednisone—prostate cancer	3.71e-05	0.000197	CcSEcCtD
Alprazolam—Insomnia—Prednisone—prostate cancer	3.69e-05	0.000195	CcSEcCtD
Alprazolam—Vision blurred—Epirubicin—prostate cancer	3.68e-05	0.000195	CcSEcCtD
Alprazolam—Paraesthesia—Prednisone—prostate cancer	3.66e-05	0.000194	CcSEcCtD
Alprazolam—Mental disorder—Doxorubicin—prostate cancer	3.64e-05	0.000193	CcSEcCtD
Alprazolam—Urticaria—Capecitabine—prostate cancer	3.64e-05	0.000193	CcSEcCtD
Alprazolam—Ill-defined disorder—Epirubicin—prostate cancer	3.62e-05	0.000192	CcSEcCtD
Alprazolam—Body temperature increased—Capecitabine—prostate cancer	3.62e-05	0.000192	CcSEcCtD
Alprazolam—Abdominal pain—Capecitabine—prostate cancer	3.62e-05	0.000192	CcSEcCtD
Alprazolam—Vomiting—Etoposide—prostate cancer	3.62e-05	0.000192	CcSEcCtD
Alprazolam—Malnutrition—Doxorubicin—prostate cancer	3.61e-05	0.000192	CcSEcCtD
Alprazolam—Flurazepam—CYP3A4—prostate cancer	3.59e-05	0.00885	CrCbGaD
Alprazolam—Agitation—Epirubicin—prostate cancer	3.59e-05	0.00019	CcSEcCtD
Alprazolam—Triazolam—CYP3A4—prostate cancer	3.59e-05	0.00884	CrCbGaD
Alprazolam—Dyspepsia—Prednisone—prostate cancer	3.59e-05	0.00019	CcSEcCtD
Alprazolam—Rash—Etoposide—prostate cancer	3.59e-05	0.00019	CcSEcCtD
Alprazolam—Dermatitis—Etoposide—prostate cancer	3.58e-05	0.00019	CcSEcCtD
Alprazolam—Headache—Etoposide—prostate cancer	3.56e-05	0.000189	CcSEcCtD
Alprazolam—Tension—Doxorubicin—prostate cancer	3.55e-05	0.000188	CcSEcCtD
Alprazolam—Decreased appetite—Prednisone—prostate cancer	3.54e-05	0.000188	CcSEcCtD
Alprazolam—Malaise—Epirubicin—prostate cancer	3.52e-05	0.000187	CcSEcCtD
Alprazolam—Fatigue—Prednisone—prostate cancer	3.51e-05	0.000186	CcSEcCtD
Alprazolam—Nervousness—Doxorubicin—prostate cancer	3.51e-05	0.000186	CcSEcCtD
Alprazolam—Vertigo—Epirubicin—prostate cancer	3.51e-05	0.000186	CcSEcCtD
Alprazolam—Syncope—Epirubicin—prostate cancer	3.5e-05	0.000186	CcSEcCtD
Alprazolam—Back pain—Doxorubicin—prostate cancer	3.5e-05	0.000185	CcSEcCtD
Alprazolam—Constipation—Prednisone—prostate cancer	3.49e-05	0.000185	CcSEcCtD
Alprazolam—Hypersensitivity—Docetaxel—prostate cancer	3.48e-05	0.000185	CcSEcCtD
Alprazolam—Oxazepam—CYP3A4—prostate cancer	3.48e-05	0.00857	CrCbGaD
Alprazolam—Muscle spasms—Doxorubicin—prostate cancer	3.48e-05	0.000184	CcSEcCtD
Alprazolam—Palpitations—Epirubicin—prostate cancer	3.45e-05	0.000183	CcSEcCtD
Alprazolam—Temazepam—CYP3A4—prostate cancer	3.44e-05	0.00846	CrCbGaD
Alprazolam—Loss of consciousness—Epirubicin—prostate cancer	3.43e-05	0.000182	CcSEcCtD
Alprazolam—Vision blurred—Doxorubicin—prostate cancer	3.41e-05	0.00018	CcSEcCtD
Alprazolam—Asthenia—Docetaxel—prostate cancer	3.39e-05	0.00018	CcSEcCtD
Alprazolam—Convulsion—Epirubicin—prostate cancer	3.38e-05	0.000179	CcSEcCtD
Alprazolam—Nausea—Etoposide—prostate cancer	3.38e-05	0.000179	CcSEcCtD
Alprazolam—Hypersensitivity—Capecitabine—prostate cancer	3.37e-05	0.000179	CcSEcCtD
Alprazolam—Feeling abnormal—Prednisone—prostate cancer	3.36e-05	0.000178	CcSEcCtD
Alprazolam—Ill-defined disorder—Doxorubicin—prostate cancer	3.35e-05	0.000178	CcSEcCtD
Alprazolam—Pruritus—Docetaxel—prostate cancer	3.34e-05	0.000177	CcSEcCtD
Alprazolam—Gastrointestinal pain—Prednisone—prostate cancer	3.33e-05	0.000177	CcSEcCtD
Alprazolam—Midazolam—CYP3A4—prostate cancer	3.33e-05	0.0082	CrCbGaD
Alprazolam—Myalgia—Epirubicin—prostate cancer	3.33e-05	0.000176	CcSEcCtD
Alprazolam—Arthralgia—Epirubicin—prostate cancer	3.33e-05	0.000176	CcSEcCtD
Alprazolam—Chest pain—Epirubicin—prostate cancer	3.33e-05	0.000176	CcSEcCtD
Alprazolam—Agitation—Doxorubicin—prostate cancer	3.32e-05	0.000176	CcSEcCtD
Alprazolam—Anxiety—Epirubicin—prostate cancer	3.31e-05	0.000176	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.3e-05	0.000175	CcSEcCtD
Alprazolam—Discomfort—Epirubicin—prostate cancer	3.29e-05	0.000174	CcSEcCtD
Alprazolam—Asthenia—Capecitabine—prostate cancer	3.28e-05	0.000174	CcSEcCtD
Alprazolam—Malaise—Doxorubicin—prostate cancer	3.26e-05	0.000173	CcSEcCtD
Alprazolam—Dry mouth—Epirubicin—prostate cancer	3.25e-05	0.000172	CcSEcCtD
Alprazolam—Vertigo—Doxorubicin—prostate cancer	3.25e-05	0.000172	CcSEcCtD
Alprazolam—Syncope—Doxorubicin—prostate cancer	3.24e-05	0.000172	CcSEcCtD
Alprazolam—Urticaria—Prednisone—prostate cancer	3.24e-05	0.000172	CcSEcCtD
Alprazolam—Pruritus—Capecitabine—prostate cancer	3.24e-05	0.000172	CcSEcCtD
Alprazolam—Diarrhoea—Docetaxel—prostate cancer	3.23e-05	0.000171	CcSEcCtD
Alprazolam—Abdominal pain—Prednisone—prostate cancer	3.22e-05	0.000171	CcSEcCtD
Alprazolam—Body temperature increased—Prednisone—prostate cancer	3.22e-05	0.000171	CcSEcCtD
Alprazolam—Confusional state—Epirubicin—prostate cancer	3.21e-05	0.00017	CcSEcCtD
Alprazolam—Palpitations—Doxorubicin—prostate cancer	3.19e-05	0.000169	CcSEcCtD
Alprazolam—Oedema—Epirubicin—prostate cancer	3.19e-05	0.000169	CcSEcCtD
Alprazolam—Loss of consciousness—Doxorubicin—prostate cancer	3.18e-05	0.000168	CcSEcCtD
Alprazolam—Infection—Epirubicin—prostate cancer	3.17e-05	0.000168	CcSEcCtD
Alprazolam—Shock—Epirubicin—prostate cancer	3.14e-05	0.000166	CcSEcCtD
Alprazolam—Convulsion—Doxorubicin—prostate cancer	3.13e-05	0.000166	CcSEcCtD
Alprazolam—Diarrhoea—Capecitabine—prostate cancer	3.13e-05	0.000166	CcSEcCtD
Alprazolam—Nervous system disorder—Epirubicin—prostate cancer	3.13e-05	0.000166	CcSEcCtD
Alprazolam—Dizziness—Docetaxel—prostate cancer	3.13e-05	0.000166	CcSEcCtD
Alprazolam—Tachycardia—Epirubicin—prostate cancer	3.11e-05	0.000165	CcSEcCtD
Alprazolam—Skin disorder—Epirubicin—prostate cancer	3.1e-05	0.000164	CcSEcCtD
Alprazolam—Hyperhidrosis—Epirubicin—prostate cancer	3.08e-05	0.000163	CcSEcCtD
Alprazolam—Arthralgia—Doxorubicin—prostate cancer	3.08e-05	0.000163	CcSEcCtD
Alprazolam—Chest pain—Doxorubicin—prostate cancer	3.08e-05	0.000163	CcSEcCtD
Alprazolam—Myalgia—Doxorubicin—prostate cancer	3.08e-05	0.000163	CcSEcCtD
Alprazolam—Anxiety—Doxorubicin—prostate cancer	3.07e-05	0.000162	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.06e-05	0.000162	CcSEcCtD
Alprazolam—Discomfort—Doxorubicin—prostate cancer	3.04e-05	0.000161	CcSEcCtD
Alprazolam—Anorexia—Epirubicin—prostate cancer	3.04e-05	0.000161	CcSEcCtD
Alprazolam—Dizziness—Capecitabine—prostate cancer	3.03e-05	0.00016	CcSEcCtD
Alprazolam—Dry mouth—Doxorubicin—prostate cancer	3.01e-05	0.000159	CcSEcCtD
Alprazolam—Vomiting—Docetaxel—prostate cancer	3.01e-05	0.000159	CcSEcCtD
Alprazolam—Hypersensitivity—Prednisone—prostate cancer	3e-05	0.000159	CcSEcCtD
Alprazolam—Rash—Docetaxel—prostate cancer	2.98e-05	0.000158	CcSEcCtD
Alprazolam—Hypotension—Epirubicin—prostate cancer	2.98e-05	0.000158	CcSEcCtD
Alprazolam—Dermatitis—Docetaxel—prostate cancer	2.98e-05	0.000158	CcSEcCtD
Alprazolam—Confusional state—Doxorubicin—prostate cancer	2.97e-05	0.000158	CcSEcCtD
Alprazolam—Headache—Docetaxel—prostate cancer	2.96e-05	0.000157	CcSEcCtD
Alprazolam—Oedema—Doxorubicin—prostate cancer	2.95e-05	0.000156	CcSEcCtD
Alprazolam—Infection—Doxorubicin—prostate cancer	2.93e-05	0.000155	CcSEcCtD
Alprazolam—Asthenia—Prednisone—prostate cancer	2.92e-05	0.000155	CcSEcCtD
Alprazolam—Vomiting—Capecitabine—prostate cancer	2.91e-05	0.000154	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.9e-05	0.000154	CcSEcCtD
Alprazolam—Shock—Doxorubicin—prostate cancer	2.9e-05	0.000154	CcSEcCtD
Alprazolam—Nervous system disorder—Doxorubicin—prostate cancer	2.89e-05	0.000153	CcSEcCtD
Alprazolam—Rash—Capecitabine—prostate cancer	2.89e-05	0.000153	CcSEcCtD
Alprazolam—Pruritus—Prednisone—prostate cancer	2.88e-05	0.000153	CcSEcCtD
Alprazolam—Insomnia—Epirubicin—prostate cancer	2.88e-05	0.000153	CcSEcCtD
Alprazolam—Dermatitis—Capecitabine—prostate cancer	2.88e-05	0.000153	CcSEcCtD
Alprazolam—Tachycardia—Doxorubicin—prostate cancer	2.88e-05	0.000153	CcSEcCtD
Alprazolam—Headache—Capecitabine—prostate cancer	2.87e-05	0.000152	CcSEcCtD
Alprazolam—Skin disorder—Doxorubicin—prostate cancer	2.87e-05	0.000152	CcSEcCtD
Alprazolam—Paraesthesia—Epirubicin—prostate cancer	2.86e-05	0.000152	CcSEcCtD
Alprazolam—Diazepam—CYP3A4—prostate cancer	2.86e-05	0.00703	CrCbGaD
Alprazolam—Hyperhidrosis—Doxorubicin—prostate cancer	2.85e-05	0.000151	CcSEcCtD
Alprazolam—Dyspnoea—Epirubicin—prostate cancer	2.84e-05	0.000151	CcSEcCtD
Alprazolam—Somnolence—Epirubicin—prostate cancer	2.83e-05	0.00015	CcSEcCtD
Alprazolam—Anorexia—Doxorubicin—prostate cancer	2.81e-05	0.000149	CcSEcCtD
Alprazolam—Nausea—Docetaxel—prostate cancer	2.81e-05	0.000149	CcSEcCtD
Alprazolam—Dyspepsia—Epirubicin—prostate cancer	2.81e-05	0.000149	CcSEcCtD
Alprazolam—Diarrhoea—Prednisone—prostate cancer	2.79e-05	0.000148	CcSEcCtD
Alprazolam—Decreased appetite—Epirubicin—prostate cancer	2.77e-05	0.000147	CcSEcCtD
Alprazolam—Hypotension—Doxorubicin—prostate cancer	2.76e-05	0.000146	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Epirubicin—prostate cancer	2.75e-05	0.000146	CcSEcCtD
Alprazolam—Fatigue—Epirubicin—prostate cancer	2.75e-05	0.000146	CcSEcCtD
Alprazolam—Constipation—Epirubicin—prostate cancer	2.73e-05	0.000144	CcSEcCtD
Alprazolam—Nausea—Capecitabine—prostate cancer	2.72e-05	0.000144	CcSEcCtD
Alprazolam—Dizziness—Prednisone—prostate cancer	2.7e-05	0.000143	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.69e-05	0.000142	CcSEcCtD
Alprazolam—Insomnia—Doxorubicin—prostate cancer	2.67e-05	0.000141	CcSEcCtD
Alprazolam—Paraesthesia—Doxorubicin—prostate cancer	2.65e-05	0.00014	CcSEcCtD
Alprazolam—Dyspnoea—Doxorubicin—prostate cancer	2.63e-05	0.000139	CcSEcCtD
Alprazolam—Feeling abnormal—Epirubicin—prostate cancer	2.63e-05	0.000139	CcSEcCtD
Alprazolam—Somnolence—Doxorubicin—prostate cancer	2.62e-05	0.000139	CcSEcCtD
Alprazolam—Gastrointestinal pain—Epirubicin—prostate cancer	2.61e-05	0.000138	CcSEcCtD
Alprazolam—Dyspepsia—Doxorubicin—prostate cancer	2.6e-05	0.000138	CcSEcCtD
Alprazolam—Vomiting—Prednisone—prostate cancer	2.59e-05	0.000137	CcSEcCtD
Alprazolam—Rash—Prednisone—prostate cancer	2.57e-05	0.000136	CcSEcCtD
Alprazolam—Dermatitis—Prednisone—prostate cancer	2.57e-05	0.000136	CcSEcCtD
Alprazolam—Decreased appetite—Doxorubicin—prostate cancer	2.56e-05	0.000136	CcSEcCtD
Alprazolam—Headache—Prednisone—prostate cancer	2.55e-05	0.000135	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.55e-05	0.000135	CcSEcCtD
Alprazolam—Fatigue—Doxorubicin—prostate cancer	2.54e-05	0.000135	CcSEcCtD
Alprazolam—Urticaria—Epirubicin—prostate cancer	2.53e-05	0.000134	CcSEcCtD
Alprazolam—Constipation—Doxorubicin—prostate cancer	2.52e-05	0.000134	CcSEcCtD
Alprazolam—Body temperature increased—Epirubicin—prostate cancer	2.52e-05	0.000134	CcSEcCtD
Alprazolam—Abdominal pain—Epirubicin—prostate cancer	2.52e-05	0.000134	CcSEcCtD
Alprazolam—Feeling abnormal—Doxorubicin—prostate cancer	2.43e-05	0.000129	CcSEcCtD
Alprazolam—Nausea—Prednisone—prostate cancer	2.42e-05	0.000128	CcSEcCtD
Alprazolam—Gastrointestinal pain—Doxorubicin—prostate cancer	2.41e-05	0.000128	CcSEcCtD
Alprazolam—Hypersensitivity—Epirubicin—prostate cancer	2.35e-05	0.000124	CcSEcCtD
Alprazolam—Urticaria—Doxorubicin—prostate cancer	2.34e-05	0.000124	CcSEcCtD
Alprazolam—Abdominal pain—Doxorubicin—prostate cancer	2.33e-05	0.000124	CcSEcCtD
Alprazolam—Body temperature increased—Doxorubicin—prostate cancer	2.33e-05	0.000124	CcSEcCtD
Alprazolam—Asthenia—Epirubicin—prostate cancer	2.29e-05	0.000121	CcSEcCtD
Alprazolam—Pruritus—Epirubicin—prostate cancer	2.26e-05	0.00012	CcSEcCtD
Alprazolam—Diarrhoea—Epirubicin—prostate cancer	2.18e-05	0.000116	CcSEcCtD
Alprazolam—Hypersensitivity—Doxorubicin—prostate cancer	2.17e-05	0.000115	CcSEcCtD
Alprazolam—Asthenia—Doxorubicin—prostate cancer	2.12e-05	0.000112	CcSEcCtD
Alprazolam—Dizziness—Epirubicin—prostate cancer	2.11e-05	0.000112	CcSEcCtD
Alprazolam—Pruritus—Doxorubicin—prostate cancer	2.09e-05	0.000111	CcSEcCtD
Alprazolam—Vomiting—Epirubicin—prostate cancer	2.03e-05	0.000107	CcSEcCtD
Alprazolam—Diarrhoea—Doxorubicin—prostate cancer	2.02e-05	0.000107	CcSEcCtD
Alprazolam—Rash—Epirubicin—prostate cancer	2.01e-05	0.000107	CcSEcCtD
Alprazolam—Dermatitis—Epirubicin—prostate cancer	2.01e-05	0.000106	CcSEcCtD
Alprazolam—Headache—Epirubicin—prostate cancer	2e-05	0.000106	CcSEcCtD
Alprazolam—Dizziness—Doxorubicin—prostate cancer	1.95e-05	0.000103	CcSEcCtD
Alprazolam—Nausea—Epirubicin—prostate cancer	1.89e-05	0.0001	CcSEcCtD
Alprazolam—Vomiting—Doxorubicin—prostate cancer	1.88e-05	9.94e-05	CcSEcCtD
Alprazolam—Rash—Doxorubicin—prostate cancer	1.86e-05	9.86e-05	CcSEcCtD
Alprazolam—Dermatitis—Doxorubicin—prostate cancer	1.86e-05	9.85e-05	CcSEcCtD
Alprazolam—Headache—Doxorubicin—prostate cancer	1.85e-05	9.79e-05	CcSEcCtD
Alprazolam—Nausea—Doxorubicin—prostate cancer	1.75e-05	9.28e-05	CcSEcCtD
Alprazolam—CYP3A7—Metabolism—CYP2E1—prostate cancer	7.49e-06	0.0001	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—RFK—prostate cancer	7.44e-06	9.96e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PGAM2—prostate cancer	7.44e-06	9.96e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SULT2B1—prostate cancer	7.44e-06	9.96e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MBTPS1—prostate cancer	7.44e-06	9.96e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NAGLU—prostate cancer	7.44e-06	9.96e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTM3—prostate cancer	7.44e-06	9.96e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AOX1—prostate cancer	7.44e-06	9.96e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—UMPS—prostate cancer	7.41e-06	9.92e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ARG2—prostate cancer	7.41e-06	9.92e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PHGDH—prostate cancer	7.41e-06	9.92e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NQO1—prostate cancer	7.41e-06	9.92e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SULT2A1—prostate cancer	7.41e-06	9.92e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	7.38e-06	9.87e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TH—prostate cancer	7.3e-06	9.77e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MED12—prostate cancer	7.29e-06	9.75e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LDHB—prostate cancer	7.27e-06	9.73e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GNG5—prostate cancer	7.23e-06	9.68e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP3A4—prostate cancer	7.23e-06	9.67e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP3A5—prostate cancer	7.14e-06	9.55e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP1B1—prostate cancer	7.1e-06	9.51e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AMACR—prostate cancer	7.05e-06	9.44e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP3A43—prostate cancer	7.05e-06	9.44e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NAT1—prostate cancer	7.05e-06	9.44e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—DEGS1—prostate cancer	7.05e-06	9.44e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SRD5A2—prostate cancer	7.05e-06	9.44e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NCOA3—prostate cancer	6.97e-06	9.32e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TCN2—prostate cancer	6.89e-06	9.22e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA3—prostate cancer	6.89e-06	9.22e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PDHA1—prostate cancer	6.89e-06	9.22e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—UCP3—prostate cancer	6.89e-06	9.22e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GGT1—prostate cancer	6.88e-06	9.21e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NCOA1—prostate cancer	6.78e-06	9.07e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HSD17B1—prostate cancer	6.73e-06	9e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP19A1—prostate cancer	6.68e-06	8.94e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HPGDS—prostate cancer	6.65e-06	8.89e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2C19—prostate cancer	6.6e-06	8.84e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HSD3B1—prostate cancer	6.57e-06	8.8e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC22A3—prostate cancer	6.57e-06	8.8e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—RXRA—prostate cancer	6.45e-06	8.63e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTT1—prostate cancer	6.45e-06	8.63e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ACHE—prostate cancer	6.45e-06	8.63e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	6.38e-06	8.54e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2A6—prostate cancer	6.37e-06	8.53e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA4—prostate cancer	6.3e-06	8.44e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TBXAS1—prostate cancer	6.3e-06	8.44e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—COMT—prostate cancer	6.21e-06	8.31e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AKR1C3—prostate cancer	6.2e-06	8.29e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTP1—prostate cancer	6.18e-06	8.27e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PRKACB—prostate cancer	6.16e-06	8.25e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	6.16e-06	8.24e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA2—prostate cancer	6.14e-06	8.22e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP17A1—prostate cancer	6.1e-06	8.16e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ITPR1—prostate cancer	6.08e-06	8.14e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SULT1A1—prostate cancer	6.07e-06	8.12e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCG5—prostate cancer	6.07e-06	8.12e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—B4GALT4—prostate cancer	6e-06	8.03e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HPGD—prostate cancer	6e-06	8.03e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA1—prostate cancer	5.93e-06	7.93e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HSD3B2—prostate cancer	5.86e-06	7.84e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTO1—prostate cancer	5.86e-06	7.84e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NAT2—prostate cancer	5.86e-06	7.84e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NCOA2—prostate cancer	5.81e-06	7.78e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TYMS—prostate cancer	5.75e-06	7.69e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTM1—prostate cancer	5.68e-06	7.6e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TNFRSF21—prostate cancer	5.64e-06	7.55e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.63e-06	7.54e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PLCB2—prostate cancer	5.62e-06	7.52e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LRP2—prostate cancer	5.62e-06	7.52e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2C18—prostate cancer	5.62e-06	7.52e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—LPL—prostate cancer	5.57e-06	7.46e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SLC5A5—prostate cancer	5.55e-06	7.42e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—P4HB—prostate cancer	5.51e-06	7.37e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP7B1—prostate cancer	5.48e-06	7.34e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MTAP—prostate cancer	5.48e-06	7.34e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2E1—prostate cancer	5.42e-06	7.25e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP1A1—prostate cancer	5.38e-06	7.21e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC22A1—prostate cancer	5.36e-06	7.17e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NQO1—prostate cancer	5.36e-06	7.17e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SULT1E1—prostate cancer	5.35e-06	7.15e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SRD5A1—prostate cancer	5.35e-06	7.15e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ERCC2—prostate cancer	5.34e-06	7.15e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.3e-06	7.09e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TH—prostate cancer	5.28e-06	7.06e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP3A4—prostate cancer	5.22e-06	6.99e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SULT2A1—prostate cancer	5.22e-06	6.99e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MED12—prostate cancer	5.14e-06	6.88e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP1B1—prostate cancer	5.14e-06	6.87e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ACSL4—prostate cancer	5.1e-06	6.82e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.1e-06	6.82e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GNG5—prostate cancer	5.1e-06	6.82e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—MTHFR—prostate cancer	5.02e-06	6.72e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GGT1—prostate cancer	4.97e-06	6.66e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPARA—prostate cancer	4.92e-06	6.59e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NCOA3—prostate cancer	4.91e-06	6.57e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NCOA1—prostate cancer	4.9e-06	6.56e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—UMPS—prostate cancer	4.89e-06	6.54e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PHGDH—prostate cancer	4.89e-06	6.54e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ARG2—prostate cancer	4.89e-06	6.54e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP19A1—prostate cancer	4.83e-06	6.46e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.83e-06	6.46e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LDHB—prostate cancer	4.79e-06	6.42e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP3A5—prostate cancer	4.71e-06	6.3e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HPGDS—prostate cancer	4.68e-06	6.27e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—RXRA—prostate cancer	4.66e-06	6.24e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2C19—prostate cancer	4.65e-06	6.23e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CAV1—prostate cancer	4.63e-06	6.2e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PDHA1—prostate cancer	4.54e-06	6.08e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TCN2—prostate cancer	4.54e-06	6.08e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—UCP3—prostate cancer	4.54e-06	6.08e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA3—prostate cancer	4.54e-06	6.08e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTT1—prostate cancer	4.54e-06	6.08e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ACHE—prostate cancer	4.54e-06	6.08e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2A6—prostate cancer	4.49e-06	6.01e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—COMT—prostate cancer	4.49e-06	6.01e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.47e-06	5.99e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTP1—prostate cancer	4.47e-06	5.98e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ITPR1—prostate cancer	4.4e-06	5.88e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AKR1C3—prostate cancer	4.37e-06	5.85e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PRKACB—prostate cancer	4.35e-06	5.82e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.34e-06	5.8e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.34e-06	5.8e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP17A1—prostate cancer	4.3e-06	5.76e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.24e-06	5.68e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CG—prostate cancer	4.22e-06	5.64e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.16e-06	5.56e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA4—prostate cancer	4.16e-06	5.56e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TYMS—prostate cancer	4.15e-06	5.56e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTM1—prostate cancer	4.11e-06	5.49e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NCOA2—prostate cancer	4.1e-06	5.48e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA2—prostate cancer	4.05e-06	5.42e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—LPL—prostate cancer	4.03e-06	5.39e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SULT1A1—prostate cancer	4e-06	5.35e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCG5—prostate cancer	4e-06	5.35e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—INS—prostate cancer	3.99e-06	5.34e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CREBBP—prostate cancer	3.91e-06	5.23e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SLC5A5—prostate cancer	3.91e-06	5.23e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA1—prostate cancer	3.91e-06	5.23e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP1A1—prostate cancer	3.89e-06	5.21e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NAT2—prostate cancer	3.86e-06	5.17e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.86e-06	5.17e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTO1—prostate cancer	3.86e-06	5.17e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ERCC2—prostate cancer	3.86e-06	5.17e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.82e-06	5.11e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NQO1—prostate cancer	3.78e-06	5.05e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TH—prostate cancer	3.72e-06	4.98e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CD—prostate cancer	3.71e-06	4.96e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PLCB2—prostate cancer	3.7e-06	4.96e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.7e-06	4.96e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LRP2—prostate cancer	3.7e-06	4.96e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.7e-06	4.95e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP3A4—prostate cancer	3.68e-06	4.93e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.66e-06	4.9e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—P4HB—prostate cancer	3.63e-06	4.86e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MTHFR—prostate cancer	3.63e-06	4.86e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP1B1—prostate cancer	3.62e-06	4.84e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPARA—prostate cancer	3.56e-06	4.76e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.53e-06	4.73e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GGT1—prostate cancer	3.51e-06	4.69e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NOS3—prostate cancer	3.5e-06	4.69e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NCOA1—prostate cancer	3.45e-06	4.62e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.44e-06	4.61e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP19A1—prostate cancer	3.4e-06	4.56e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MED12—prostate cancer	3.39e-06	4.53e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GNG5—prostate cancer	3.36e-06	4.5e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CAV1—prostate cancer	3.35e-06	4.48e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—RXRA—prostate cancer	3.28e-06	4.4e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NCOA3—prostate cancer	3.24e-06	4.33e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CB—prostate cancer	3.23e-06	4.32e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTGS2—prostate cancer	3.2e-06	4.28e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.19e-06	4.28e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—COMT—prostate cancer	3.16e-06	4.23e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTP1—prostate cancer	3.15e-06	4.21e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ITPR1—prostate cancer	3.1e-06	4.15e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HPGDS—prostate cancer	3.09e-06	4.13e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.07e-06	4.11e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CG—prostate cancer	3.05e-06	4.08e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.05e-06	4.08e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ACHE—prostate cancer	3e-06	4.01e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTT1—prostate cancer	3e-06	4.01e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.96e-06	3.96e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TYMS—prostate cancer	2.93e-06	3.92e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTM1—prostate cancer	2.89e-06	3.87e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—INS—prostate cancer	2.89e-06	3.86e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.88e-06	3.86e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PRKACB—prostate cancer	2.87e-06	3.84e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—LPL—prostate cancer	2.84e-06	3.8e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.84e-06	3.8e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CREBBP—prostate cancer	2.83e-06	3.78e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTEN—prostate cancer	2.79e-06	3.74e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.74e-06	3.67e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ERCC2—prostate cancer	2.72e-06	3.64e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NCOA2—prostate cancer	2.7e-06	3.62e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CD—prostate cancer	2.68e-06	3.59e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—EP300—prostate cancer	2.66e-06	3.56e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.58e-06	3.45e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MTHFR—prostate cancer	2.56e-06	3.42e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NOS3—prostate cancer	2.53e-06	3.39e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.52e-06	3.37e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPARA—prostate cancer	2.51e-06	3.36e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NQO1—prostate cancer	2.49e-06	3.33e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TH—prostate cancer	2.45e-06	3.28e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.39e-06	3.2e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CAV1—prostate cancer	2.36e-06	3.16e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CB—prostate cancer	2.34e-06	3.13e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTGS2—prostate cancer	2.31e-06	3.1e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GGT1—prostate cancer	2.31e-06	3.09e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NCOA1—prostate cancer	2.28e-06	3.05e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.25e-06	3.02e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.24e-06	3e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—RXRA—prostate cancer	2.17e-06	2.9e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.15e-06	2.88e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—COMT—prostate cancer	2.09e-06	2.79e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTP1—prostate cancer	2.08e-06	2.78e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ITPR1—prostate cancer	2.04e-06	2.74e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—INS—prostate cancer	2.03e-06	2.72e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTEN—prostate cancer	2.02e-06	2.7e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CREBBP—prostate cancer	1.99e-06	2.67e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.97e-06	2.64e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TYMS—prostate cancer	1.93e-06	2.58e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—EP300—prostate cancer	1.92e-06	2.58e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTM1—prostate cancer	1.91e-06	2.55e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.89e-06	2.53e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—LPL—prostate cancer	1.87e-06	2.51e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.81e-06	2.42e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ERCC2—prostate cancer	1.79e-06	2.4e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NOS3—prostate cancer	1.78e-06	2.39e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MTHFR—prostate cancer	1.69e-06	2.26e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPARA—prostate cancer	1.65e-06	2.21e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.65e-06	2.2e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTGS2—prostate cancer	1.63e-06	2.18e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AKT1—prostate cancer	1.61e-06	2.15e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CAV1—prostate cancer	1.56e-06	2.08e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.42e-06	1.91e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTEN—prostate cancer	1.42e-06	1.9e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.42e-06	1.9e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—EP300—prostate cancer	1.36e-06	1.82e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—INS—prostate cancer	1.34e-06	1.8e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CREBBP—prostate cancer	1.31e-06	1.76e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.25e-06	1.67e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NOS3—prostate cancer	1.18e-06	1.57e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AKT1—prostate cancer	1.16e-06	1.56e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.09e-06	1.45e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGS2—prostate cancer	1.08e-06	1.44e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CA—prostate cancer	1e-06	1.34e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTEN—prostate cancer	9.38e-07	1.26e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—EP300—prostate cancer	8.95e-07	1.2e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AKT1—prostate cancer	8.2e-07	1.1e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.62e-07	8.86e-06	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AKT1—prostate cancer	5.41e-07	7.24e-06	CbGpPWpGaD
